Vinai Gondi, Bridget Koontz, Priya Rastogi, Lisa Lenrow named to NRG Oncology committee leadership (@nrgonc.bsky.social) https://cancerletter.com/in-brief/20251031_6c/

The November FORTE Fridays newsletter is now available. Check it out here ➡️https://conta.cc/3X7BEay @fortestudy.bsky.social

Registration for the #NRG2026 Winter Meeting is now OPEN! Virtual sessions start the week of Jan 12 and the in-person dates are Jan 22-24. Join us and register soon ↪️https://conta.cc/4qNhcJw

This #VeteransDay our NRG Oncology podcast co-hosts sit with NRG VA-MTF Subcommittee Chair, Dr. Sandulache, to discuss the subcommittee and their goals as well as clinical research at VA sites. Subscribe or follow: www.NRGOncology.org/Podcast

New Episode Alert! Just in time for #PancreaticCancerAwarenessMonth in November, Dr. Sanford discusses the recently activated NRG-GI011 lapse study for dose-escalated RT in LAPC - Tune in: nrgoncology.org/Podcast

Happy #Halloween! Have you scheduled your yearly #mammogram yet? Early detection can save lives! Don't delay! #BreastCancerAwarenessMonth #BCSM #clinicaltrials #breastcancer #inOctoberWeWearPink #October

Want to learn about the newest NRG trial in #pancreaticcancer - Our Podcast co-hosts sit with Dr. Sanford to discuss the NRG-GI011 "LAP100" trial of dose escalated RT next week. Follow us where you get your podcasts or listen at www.nrgoncology.org/podcast#pancreaticcancer

ATTN NRG members: NRG Oncology System Updates – Upcoming Participant Entry Downtime ➡️https://conta.cc/47PhI2g

PRESS RELEASE: NRG Oncology Adds New Leadership Members to Ancillary Projects, Brain Tumor, Breast Cancer, and Patient Advocate Committees - Read more: ow.ly/5qor50XjQaQ

October is #LiverCancerAwarenessMonth. Recently activated - NRG-GI012 (HELIO-RT) will be testing if adding SBRT to immunotherapy improves survival compared to IO-based systemic therapy alone, in patients with advanced primary liver cancer, or hepatocellular cancer.

Start your Thursday off right with a NEW episode of The NRG Oncology Podcast! Today we discuss all things NCORP and APPs with NRG NCORP PI Deb Bruner. Tune in and follow: nrgoncology.org/Podcast

Our October Newsletter edition is available! Read about our #BreastCancer Awareness Features, a special study highlight for ComboMATCH N5, current trials on deck, and more! Check it out: conta.cc/4gQfBhP

Follow us now to listen to episodes as they air! This THURSDAY, Dr. Deb Bruner talks NCORP, the importance of reaching the community in research & the major role Advanced Practice Providers play in helping us achieve that goal nrgoncology.org/Podcast

Protocol Activation! Effective October 07, 2025, NRG-GI012 is open to patient entry. NRG-GI012: Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer with Macrovascular Invasion (HELIO-RT) Learn more: conta.cc/4gUhIkD

On Monday, Sept 29th, we announced the activation of NRG-GY037, a pivotal Phase III randomized trial for patients with high-risk, locally advanced cervical cancer. PI: Jyoti Mayadev, MD, UCSDHealth Read more: conta.cc/3Iwh00d

October is #BreastCancerAwarenessMonth. Whether you are due for your yearly check in October or any other month - consider this a reminder to get screened with a yearly mammogram - early detection is key! Learn more: go.usa.gov/xhWrf

The NRG Oncology Podcast is looking at the results of our Late-Breaking Session presentations at #ASTRO25 on NRG-LU005 QOL and the proton cohort of NRG-BN001! Follow us now to be in the loop: nrgoncology.org/Podcast @henryfordhealth.bsky.social

NRG has SEVERAL great presentations coming up at #ASTRO25: The NRG Oncology Podcast will dive deeper into results such as the NRG-GU005 and RadComp presentations in the Plenary Session. Learn more and follow: nrgoncology.org/Podcast

NEW EPISODE! We are talking precision oncology, clinical research, and industry collaboration with @weldeiry.bsky.social sky.social Follow our podcast: nrgoncology.org/Podcast @americancancersoc.bsky.social

NRG Oncology Aims to Move the Needle in Prostate Cancer Outcomes. September is #ProstateCancerAwarenessMonth. The theme of this year’s campaign is “awareness needs action.” We have multiple active studies in the prostate cancer space. Learn more ➡️https://ow.ly/Hcqt50WXwn6

Welcome new NRG PAC member Lauren Hilliard! In our Sept newsletter, she discusses her role as a clinical research coordinator for endometrial & cervical cancers, placing a strong emphasis on the importance of patients' voices. ow.ly/ynsv50WXv5Q

Our September eNewsletter is out! This issue includes updates about our #prostatecancer trials portfolio, upcoming cervical cancer study NRG-GY037, SOROCk & more - Advocate Angle, PSC column and @fortestudy.bsky.social updates! Check it out ↪️https://conta.cc/45LwfLF

NRG NCORP is soliciting LOIs in preparation for the next NCORP pilot grant RFA. Anyone interested in applying must submit a Letter of Intent (LOI) by October 24, 2025. Learn more ➡️https://conta.cc/4nw14Km

On September 18th, our podcast takes a look at the world of #precisiononcology and clinical research & industry collaboration with @weldeiry.bsky.social Follow our podcast: nrgoncology.org/Podcast @americancancersoc.bsky.social

Call for PSC Leadership Roles (2) and General Membership. Read more: conta.cc/3JHlLEu

The FORTE Fridays eNewsletter for September is now available! Read it here: conta.cc/461e03x @fortestudy.bsky.social

Annual Call for NRG Committee Member Applications. Read more: conta.cc/3JHlLEu

September is #OvarianCancerAwarenessMonth. Ovarian cancer causes abnormal growth of cells in one or both of the ovaries. The NCI website is a helpful resource to learn more about the specific types of gynecologic cancers. #GynecologicCancerAwarenessMonth cancer.gov/types/ovarian

September is #ProstateCancerAwarenessMonth. Prostate cancer mainly affects men over the age of 50, with 1 in 8 men being diagnosed in their lifetime. Visit @theNCI website to learn more about prevention, screening, statistics, and research. cancer.gov/types/prostate

NRG Oncology seeking Chair/Vice Chair applications for the Medical Oncology, Lung Cancer, and Developmental Therapeutics Committees. More information: conta.cc/4mWPk2S Applications due Sept 29th.

NRG-GU015, the "ARCHER" study, recently activated! We interviewed study PI, Scott Delacroix, and co-PI @himanshunagarmd.bsky.social on this phase 3 study of adaptive radiation and chemotherapy for muscle invasive #bladdercancer. Watch the full interview here: youtu.be/qCc-htw39to

Now live! Learn all about the Ancillary Projects Committee and the process for ancillary projects at NRG Oncology in our latest podcast with Dr. Waggoner. Tune in and be sure to follow us: nrgoncology.org/Podcast

Call for Leadership Applications - Seeking Chairs for the following committees: •Ancillary Projects •Brain •Breast •PCOR •Medical Physics Subcommittee Application Submission Deadlines: September 19, 2025 conta.cc/3V56FLg

The August edition of our NRG Currents newsletter is out! This month's highlights include the just activated ARCHER NRG-GU015 study, a message from new PAC chair @tambre.bsky.social, NRG podcast updates, @fortestudy.bsky.social updates, NRG news & more! ➡️https://conta.cc/3IZOfc0

New episode next week! Our NRG Oncology Podcast hosts discuss all things ancillary project with APC Committee Chair, Dr. Waggoner. Find us and follow so you can be ready to tune in when we air nrgoncology.org/Podcast @clevelandclinic.bsky.social

PRESS RELEASE: NRG Oncology Opens New “ARCHER” Clinical Trial (NRG-GU015) Testing a Shorter Treatment Duration of Radiation Therapy for Muscle Invasive Bladder Cancer - Read more: ow.ly/6lyF50WG0GN @himanshunagarmd.bsky.social @mskcancercenter.bsky.social

PRESS RELEASE: NRG Oncology Appoints New NCORP and Veteran Affairs Research Leadership - Read the release: ow.ly/CnnF50WFic5 @gwcancercenter.bsky.social @uazcancercenter.bsky.social

PRESS RELEASE: Dual Immune Checkpoint Inhibition with Radiotherapy does not Improve Progression-Free Survival for Patients with Newly Diagnosed MGMT-unmethylated Glioblastoma - Read the release: ow.ly/cgML50WFgLV @columbiamed.bsky.social ed @columbiacancer.bsky.social

August FORTE Fridays! #NRG2025 update, Important amendment reminders, next Site and VA Site Calls, & more! ↪️ conta.cc/3J5VuPJ @fortestudy.bsky.social

Join the NRG Protocol Support Committee (PSC) for their inaugural “Discuss With Us” monthly session. August's session is about GYN Oncology Essentials: A Clinical Refresher. Learn more and to register ↪️https://ow.ly/kmu050WAHXs

The NRG-BR009 OFSET study hopes to answer important ?s for young women: is chemo needed, who does it benefit & at what cost with potential side effects? A set of video tools to help investigators talk with patients about the trial have been created: ow.ly/7nqF50WAaec

Thank you to our attendees for joining us for #NRG2025 & to those who joined us virtually for our online sessions. Check the NRG website in the coming days for session presentations. nrgoncology.org/Summer2025Mtg In the meantime, here's a little #TBT reel for your enjoyment!

NEW EPISODE on the pragmatic PREEMPT Study (NRG-CC014) comparing the effects of adding RT to usual care on the occurrence of bone-related complications for patients w/ high-risk bone mets that are asymptomatic nrgoncology.org/Podcast #bonecancer @fredhutch.bsky.social

THIS WEEK! We discuss The NRG-CC014 "PREEMPT" study of the effects of adding radiation therapy on the occurrence of bone-related complications in patients w/ high-risk bone mets. nrgoncology.org/Podcast

NOW LIVE! Just announced at #NRG2025: We interview Immediate Past Chair of the Lung Cancer Committee Dr. Jeff Bradley to discuss #LungCancer in NRG and the importance of mentoring the next generation of researchers: nrgoncology.org/Podcasts

Curious about the ins-and-outs of NRG Membership and the NRG Membership Committee? Deputy Group Chair of Membership & Research Integrity @dsmgyo.bsky.social outlines all this information in this episode: nrgoncology.org/Podcast

Dr. Ian Krop @yalecancer.bsky.social discussing ADCs in #breastcancer to a full house at the #NRG2025 Summer Symposium.

We’re here! Registration is this way! #NRG2025 Follow us as we post updates over the next 3 days!

That's a wrap on our #NRG2025 CDE Workshop! Very interesting presentations about worthwhile advocacy projects and the newly activated HEAL-ABC trial. The recording of this workshop should be available in about a week for those who weren't able to join the live session.

Virtual Sessions continue today for #NRG2025. Check out this morning's special broadcast for more information: ow.ly/Klng50WsHmJ